270 related articles for article (PubMed ID: 16164124)
21. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status.
Ko YH; Cho EY; Kim JE; Lee SS; Huh JR; Chang HK; Yang WI; Kim CW; Kim SW; Ree HJ
Histopathology; 2004 May; 44(5):480-9. PubMed ID: 15139996
[TBL] [Abstract][Full Text] [Related]
22. Metalloproteinases in juvenile angiofibroma--a collagen rich tumor.
Duerr S; Wendler O; Aigner T; Karosi S; Schick B
Hum Pathol; 2008 Feb; 39(2):259-68. PubMed ID: 17950779
[TBL] [Abstract][Full Text] [Related]
23. [Expression and significance of P53 and P21 in nasal NK/T-cell lymphoma].
Xu G; Wang HF; He G; Xu G
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):132-6. PubMed ID: 20369488
[TBL] [Abstract][Full Text] [Related]
24. Transcription factors engaged in development of NK cells are commonly expressed in nasal NK/T-cell lymphomas.
Zhang S; Li T; Zhang B; Nong L; Aozasa K
Hum Pathol; 2011 Sep; 42(9):1319-28. PubMed ID: 21329961
[TBL] [Abstract][Full Text] [Related]
25. Three cases of extranodal NK/T-cell lymphoma of the nasal type diagnosed by nasal brush cytology.
Kishimoto K; Kitamura T; Hirayama Y; Tate G; Mitsuya T
Diagn Cytopathol; 2007 Feb; 35(2):125-9. PubMed ID: 17230578
[TBL] [Abstract][Full Text] [Related]
26. Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma.
Kawata N; Nagane Y; Hirakata H; Ichinose T; Okada Y; Yamaguchi K; Takahashi S
Urology; 2007 Jun; 69(6):1049-53. PubMed ID: 17572184
[TBL] [Abstract][Full Text] [Related]
27. [Expression and significance of matrix metalloproteinase and tissue inhibitor of metalloproteinase in nasal cavity squamous cell carcinoma].
Zheng Y; Ding J; Wang CL; Jiao SS; Qu LM; Bahargul ; Bao H; Chen X
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Apr; 46(4):299-302. PubMed ID: 21624249
[TBL] [Abstract][Full Text] [Related]
28. Expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in tissues with a diagnosis of childhood lymphoma.
Bozkurt C; Ertem U; Oksal A; Sahin G; Yüksek N; Birgen D
Pediatr Hematol Oncol; 2008 Sep; 25(7):621-9. PubMed ID: 18850474
[TBL] [Abstract][Full Text] [Related]
29. Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas.
Nabeshima K; Suzumiya J; Nagano M; Ohshima K; Toole BP; Tamura K; Iwasaki H; Kikuchi M
J Pathol; 2004 Mar; 202(3):341-51. PubMed ID: 14991900
[TBL] [Abstract][Full Text] [Related]
30. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
[TBL] [Abstract][Full Text] [Related]
31. Features of intestinal T-cell lymphomas in Chinese population without evidence of celiac disease and their close association with Epstein-Barr virus infection.
Zhang WY; Li GD; Liu WP; Ouyang Q; Ren XC; Li FY; Xu H
Chin Med J (Engl); 2005 Sep; 118(18):1542-8. PubMed ID: 16232331
[TBL] [Abstract][Full Text] [Related]
32. Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling.
Ng SB; Selvarajan V; Huang G; Zhou J; Feldman AL; Law M; Kwong YL; Shimizu N; Kagami Y; Aozasa K; Salto-Tellez M; Chng WJ
J Pathol; 2011 Mar; 223(4):496-510. PubMed ID: 21294123
[TBL] [Abstract][Full Text] [Related]
33. Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps.
Chen YS; Langhammer T; Westhofen M; Lorenzen J
Allergy; 2007 Jan; 62(1):66-72. PubMed ID: 17156344
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
[TBL] [Abstract][Full Text] [Related]
35. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.
Lee J; Park YH; Kim WS; Lee SS; Ryoo BY; Yang SH; Park KW; Kang JH; Park JO; Lee SH; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Ko YH; Ahn YC; Park K
Eur J Cancer; 2005 Jul; 41(10):1402-8. PubMed ID: 15963893
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type.
Wang B; Li XQ; Ma X; Hong X; Lu H; Guo Y
Am J Hematol; 2008 Oct; 83(10):795-9. PubMed ID: 18756548
[TBL] [Abstract][Full Text] [Related]
37. [Extranodal nasal type NK/T-cell lymphoma: the expression of Epstein-Barr virus latent membrane protein 1 and its significance of prognosis].
Zhao S; Liu WP; Zhang WY; Li GD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):338-40. PubMed ID: 15931862
[TBL] [Abstract][Full Text] [Related]
38. Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection.
Feng YF; Wu QL; Zong YS
Ai Zheng; 2007 Nov; 26(11):1170-6. PubMed ID: 17991313
[TBL] [Abstract][Full Text] [Related]
39. [Nasal/nasopharyngeal T/NK-cell lymphomas with evident angiogenic activity].
Zhang HY; Huang GS; Zhu HT; Zhang YQ; Guo Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):317-9. PubMed ID: 12940067
[TBL] [Abstract][Full Text] [Related]
40. [Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas].
Zhang YJ; Ren ZM; Wu QL; He ZY; Huang Y; Xia YF; Lin TY; Cui NJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):217-21. PubMed ID: 16875549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
